Ginsenoside C-K hexapropionate ester

Overview

Ginsenoside C-K hexapropionate ester (Structure 2) is a selective agonist of LXRα , with no significant activation effect on LXRβ. Ginsenoside C-K hexapropionate ester upregulates the expression of downstream genes such as ABCA1 by activating LXRα , promoting reverse cholesterol transport, and reducing lipid deposition in macrophage-derived foam cells. It can be used in the research of atherosclerosis. Ginsenoside C-K hexapropionate ester is a derivative synthesized from ginsenoside Compound K, an active metabolite of Panax notoginseng saponins, by modification with propionic anhydride.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Atherosclerosis | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Vitamin D Related/Nuclear Receptor | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > LXR

Product Information

• Catalog No.: HY-185104
• CAS No.: 2861254-89-7
• Molecular Formula: C54H86O14
• Molecular Weight: 959.25
• Purity: 98.88%
• Storage: 4°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Solubility: ≥ 2.5 mg/mL (2.61 mM); Clear solution
• Availability: In-stock

Source

Original product source